Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 19/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | PGR | P06401 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396844 | 1.00 | AR (0.56) | ARGLAPOLBGAATSHR | |
| SCHEMBL15320326 | 0.85 | AR (0.45) | ARGLAPOLBGAATSHR | |
| SCHEMBL15319977 | 0.85 | AR (0.45) | ARGLAPOLBGAATSHR | |
| SCHEMBL15319981 | 0.85 | KDM4E (0.49) | ARGLAPOLBGAATSHR | |
| SCHEMBL30084901 | 0.84 | GLA (0.55) | ARGLAPOLBGAATSHR | |
| SCHEMBL324114 | 0.84 | GLA (0.55) | ARGLAPOLBGAATSHR | |
| SCHEMBL28932082 | 0.81 | AR (0.65) | AR | |
| SCHEMBL31019374 | 0.80 | GAA (0.55) | ARGLAPOLBGAATSHR | |
| SCHEMBL1762580 | 0.80 | GAA (0.55) | ARGLAPOLBGAATSHR | |
| SCHEMBL1772784 | 0.80 | KDM4E (0.52) | ARGLAPOLBGAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1722 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119409577-B | Preparation method of 2-fluoro-4-nitrobenzoic acid | 山东极地医药科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119409577-A | Preparation method of 2-fluoro-4-nitrobenzoic acid | 山东极地医药科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-115394924-B | Organic-inorganic hybrid perovskite solar cell based on interface modification layer | 太原理工大学 | 2025-01-24 | — | — | CN | claimed |
| CN-118619837-A | Preparation method of 2-trifluoromethyl-4-aminobenzoic acid | 江西金丰药业有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-116199633-B | Method for preparing revalutamide | 甘肃省化工研究院有限责任公司 | 2024-05-31 | — | — | CN | claimed |
| CN-115181043-B | Method for preparing 4-isothiocyanato-2- (trifluoromethyl) benzonitrile by continuous flow | 爱斯特(成都)生物制药股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-116082246-B | Synthesis method of ethylene thiourea derivative | 长沙泽达医药科技有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-116199633-A | Method for preparing revalutamide | 甘肃省化工研究院有限责任公司 | 2023-06-02 | — | — | CN | claimed |
| CN-116082246-A | Synthesis method of ethylene thiourea derivative | 长沙泽达医药科技有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-113717086-B | Preparation method of green and environment-friendly 4-isothiocyanato-2- (trifluoromethyl) benzonitrile | 江西金丰药业有限公司 | 2023-03-10 | — | — | CN | claimed |
| WO-2003059899-A1 | GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL FORMULATIONS CONTAINING THEM AND USES THEREOF | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| US-6583306-B1 | Forming dioxolane derivative of citramalic acid; replacing free carboxylic acid with leaving group; coupling with hydroxyl, amino, thiol, sulphinyl or sulphonyl reactive compound; deprotecting; amidation with aniline derivitive | NOBEX CORPORATION | 2003-06-24 | — | — | US | claimed |
| CN-1409702-A | Methods for asymmetrically synthesizing enantiomer of casodex, its derivatives and intermediate thereof | NOBEX CORP (US) | 2003-04-09 | — | — | CN | claimed |
| EP-1189898-B1 | PROCESS FOR THE SYNTHESIS OF N-(4-CYANO-3-TRIFLUOROMETHYLPHENYL)-3-(4-FLUOROPHENYLSULPHONYL)-2-HYDROXY-2-METHYLPROPIONAMIDE | RICHTER GEDEON VEGYESZET (HU) | 2003-03-12 | — | — | EP | claimed |
| US-20030045741-A1 | Novel process for preparing rac-bicalutamide and its intermediates | TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG (HU) | 2003-03-06 | — | — | US | claimed |
| WO-2002100339-A2 | NOVEL PROCESS FOR PREPARING RAC-BICALUTAMIDE AND ITS INTERMEDIATES | BIOGAL GYOGYSZERGYAR RT. (HU) | 2002-12-19 | — | — | WO | claimed |
| EP-1222165-A2 | METHODS OF ASYMMETRICALLY SYNTHESIZING ENANTIOMERS OF CASODEX, ITS DERIVATIVES AND INTERMEDIATES THEREOF | Nobex Corporation (US) | 2002-07-17 | — | — | EP | claimed |
| EP-1189898-A1 | PROCESS FOR THE SYNTHESIS OF N-(4-CYANO-3-TRIFLUOROMETHYLPHENYL)-3-(4-FLUOROPHENYLSULPHONYL)-2-HYDROXY-2-METHYLPROPIONAMIDE | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 2002-03-27 | — | — | EP | claimed |
| WO-2001028990-A2 | METHODS OF ASYMMETRICALLY SYNTHESIZING ENANTIOMERS OF CASODEX, ITS DERIVATIVES AND INTERMEDIATES THEREOF | NOBEX CORPORATION (US) | 2001-04-26 | — | — | WO | claimed |
| WO-2001000608-A1 | PROCESS FOR THE SYNTHESIS OF N-(4-CYANO-3-TRIFLUOROMETHYLPHENYL)-3-(4-FLUOROPHENYLSULFONYL)-2-HYDROXY-2-METHYLPROPIONAMIDE | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 2001-01-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045741-A1 | Novel process for preparing rac-bicalutamide and its intermediates | RAC2, RAC3, RAC1 | AR 78/4885GLA 4077/4885POLB 2012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.